Literature DB >> 23096071

Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease.

Takeshi Nakano, Shinji Ono, Junji Yamaguchi, Ryu Sugimoto, Naohiro Yamaguchi, Yoshiro Morimoto, Tatsuya Kubo, Hiroki Ozawa, Naohiro Kurotaki.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23096071     DOI： 10.1007/s00415-012-6720-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

Review 1.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

Review 2.  ECT and tardive dyskinesia.

Authors:  D P Hay; L Hay; B Blackwell; H R Spiro
Journal:  J Geriatr Psychiatry Neurol       Date:  1990 Apr-Jun       Impact factor: 2.680

Review 3.  Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.

Authors:  T C Andrews; D J Brooks
Journal:  Mol Med Today       Date:  1998-12

4.  Huntington disease in Maryland: clinical aspects of racial variation.

Authors:  S E Folstein; G A Chase; W E Wahl; A M McDonnell; M F Folstein
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

5.  Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

Authors:  Mohamed R Mughal; Akanksha Baharani; Srinivasulu Chigurupati; Tae Gen Son; Edmund Chen; Peter Yang; Eitan Okun; Thiruma Arumugam; Sic L Chan; Mark P Mattson
Journal:  Hum Mol Genet       Date:  2010-11-24       Impact factor: 6.150

6.  ECT in the Treatment of Organic Psychosis in Huntington's Disease.

Authors:  Dwight L. Evans; Cort A. Pedersen; Manuel E. Tancer
Journal:  Convuls Ther       Date:  1987

7.  A controlled psychiatric study of individuals at risk for Huntington's disease.

Authors:  R S Shiwach; C G Norbury
Journal:  Br J Psychiatry       Date:  1994-10       Impact factor: 9.319

8.  Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome.

Authors:  C Ward; G M Stern; R T Pratt; P McKenna
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 9.  Huntington's disease: update and review of neuropsychiatric aspects.

Authors:  M F Mendez
Journal:  Int J Psychiatry Med       Date:  1994       Impact factor: 1.210

10.  Psychiatric syndromes in Huntington's disease.

Authors:  E D Caine; I Shoulson
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112
View more
  3 in total

Review 1.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

2.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086

3.  Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.

Authors:  Walied Mowafi; Jon Millard
Journal:  BJPsych Bull       Date:  2021-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.